Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Cell Stem Cell|November 4, 2022
Glioblastoma stem cell HISTArionicsSiva Kumar Natarajan, Sriram VennetiCancer Research|July 3, 2019
Poly Combs the Immune System: PRC2 Loss in Malignant Peripheral Nerve Sheath Tumors Can Dampen Immune ResponsesSiva Kumar Natarajan, Sriram VennetiCellular and Molecular Bioengineering|November 14, 2019
Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint InhibitorAnujan Ramesh, Siva Kumar Natarajan, Dipika Nandi, et al.Annual Review of Pathology|November 18, 2025
Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in GliomasSiva Kumar Natarajan, Matthew Pun, James Haggerty-Skeans, et al.ACS Nano|September 23, 2016
Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer EfficacyAshish Kulkarni, Siva Kumar Natarajan, Vineethkrishna Chandrasekar, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|April 17, 2016
Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancerAshish A Kulkarni, Vijay Elakkya Vijaykumar, Siva Kumar Natarajan, et al.ACS Nano|June 4, 2016
Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in CancerAaron Goldman, Ashish Kulkarni, Mohammad Kohandel, et al.Biosensors & Bioelectronics|April 4, 2017
A microfluidic platform for drug screening in a 3D cancer microenvironmentHardik J Pandya, Karan Dhingra, Devbalaji Prabhakar, et al.Nature Biomedical Engineering|April 9, 2019
A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancerAshish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan, et al.Pageof 2